Gastric Neuroendocrine Tumors from Long‐Term Proton Pump Inhibitor Users are Indolent Tumors with Good Prognosis
Aims Proton pump inhibitors (PPIs) are among the most widely used medications in the United States. Most PPI users have persistent hypergastrinemia during treatment. However, gastric neuroendocrine …